Paper9809459
Peptidylglycine alpha-amidating mono-oxygenase: neuropeptide amidation as a target for drug design.
Bolkenius FN and 1 other. Gen Pharmacol, 1998. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Peptidylglycine alpha-amidating mono-oxygenase: neuropeptide amidation as a target for drug design. Papers, record 9809459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9809459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peptidylglycine alpha-amidating mono-oxygenase: neuropeptide amidation as a target for drug design.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Design | Major topic |
| Mixed Function Oxygenases | Major topic |
| Multienzyme Complexes | Major topic |
| Neuropeptides | Major topic |
| Animals | |
| Enzyme Inhibitors | |
| Humans |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39810605 | Cocaine-Induced Remodeling of the Rat Brain Peptidome: Quantitative Mass Spectrometry Reveals Anatomically Specific Patterns of Cocaine-Regulated Peptide Changes. | ACS Chem Neurosci | 2025 | https://conductscience.org/library/papers/39810605 | PubMed |
| 39137152 | Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/39137152 | PubMed |
| 37402878 | Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma. | Sci Rep | 2023 | https://conductscience.org/library/papers/37402878 | PubMed |
| 32374750 | Comparison of a human neuronal model proteome upon Japanese encephalitis or West Nile Virus infection and potential role of mosquito saliva in neuropathogenesis. | PLoS One | 2020 | https://conductscience.org/library/papers/32374750 | PubMed |
| 25123359 | Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells. | BMC Biotechnol | 2014 | https://conductscience.org/library/papers/25123359 | PubMed |
| 24533265 | Parasite neuropeptide biology: Seeding rational drug target selection? | Int J Parasitol Drugs Drug Resist | 2012 | https://conductscience.org/library/papers/24533265 | PubMed |
| 21043511 | Evidence for substrate preorganization in the peptidylglycine α-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/21043511 | PubMed |
| 20488212 | A PAL for Schistosoma mansoni PHM. | Mol Biochem Parasitol | 2010 | https://conductscience.org/library/papers/20488212 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PAM | 5066 | PubTator's text mining | https://conductscience.org/library/genes/5066 | NCBI Gene |
| TAC1 | 6863 | PubTator's text mining | https://conductscience.org/library/genes/6863 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9809459
GET https://conductscience.org/api/papers/v1/9809459/authors